Sickle cell anemia. Available online: http://apps.who.int/gb/archive/pdf_files/wha59/a59_9-en.pdf (accessed on 11 November 2018).
Aguilar Martinez, P.; Angastiniotis, M.; Eleftheriou, A.; Gulbis, B.; Mañú Pereira Mdel, M.; Petrova-Benedict, R.; Corrons, J.L. Haemoglobinopathies in Europe: Health & migration policy perspectives. Orphanet J. Rare Dis. 2014, 9, 97. [CrossRef] [PubMed]
Lê, P.Q.; Gulbis, B.; Dedeken, L.; Dupont, S.; Vanderfaeillie, A.; Heijmans, C.; Huybrechts, S.; Devalck, C.; Efira, A.; Dresse, M.F.; et al. Survival among children and adults with sickle cell disease in belgium: Benefit from hydroxyurea treatment. Pediatr. Blood Cancer 2015, 62, 1956–1961. [CrossRef] [PubMed]
Gaston, M.H.; Verter, J.I.; Woods, G.; Pegelow, C.; Kelleher, J.; Presbury, G.; Zarkowsky, H.; Vichinsky, E.; Iyer, R.; Lobel, J.S.; et al. For the Prophylactic Penicillin Study Group. Prophylaxis with oral penicillin in children with sickle cell anemia. A randomized trial. N. Engl. J. Med. 1986, 314, 1593–1599. [CrossRef] [PubMed]
Castilla-Rodríguez, I.; Cela, E.; Vallejo-Torres, L.; Valcárcel-Nazco, C.; Dulín, E.; Espada, M.; Rausell, D.; Mar, J.; Serrano-Aguilar, P. Cost-effectiveness analysis of newborn screening for sickle-cell disease in Spain. Exp. Opin. Orphan Drugs 2016, 4, 567–575. [CrossRef]
Ketelslegers, O.; Eyskens, F.; Boemer, F.; Bours, V.; Minon, J.M.; Gulbis, B. Epidemiological data on sickle cell disease in Belgium. Belg. J. Hematol. 2015, 6, 135–141.
Wolff, F.; Cotton, F.; Gulbis, B. Screening for haemoglobinopathies on cord blood: Laboratory and clinical experience. J. Med. Screen. 2012, 19, 116–122. [CrossRef] [PubMed]
Boemer, F.; Cornet, Y.; Libioulle, C.; Segers, A.; Bours, V.; Schoos, R. 3-Years experience review of neonatal screening for hemoglobin disorders using tandem mass spectrometry. Clin. Chim. Acta 2011, 412, 1476–1479. [CrossRef] [PubMed]
Weatherall, D.J. The inherited diseases of hemoglobin are an emerging global health burden. Blood 2010, 115, 4331–4436. [CrossRef] [PubMed]
Piel, F.B.; Tatem, A.J.; Huang, Z.; Gupta, S.; Williams, T.N.; Weatherall, D.J. Global migration and the changing distribution of sickle haemoglobin: A quantitative study of temporal trends between 1960 and 2000. Lancet Glob. Health 2014, 2, 80–89. [CrossRef]
Migrations en Belgique: Données statistiques. Available online: www.myria.be/files/Migration-rapport-2015-C2.pdf (accessed on 7 October 2018).
Vichinsky, E.; Hurst, D.; Earles, A.; Kleman, K.; Lubin, B. Newborn screening for sickle cell disease: Effect on mortality. Pediatrics 1988, 81, 749–755. [PubMed]
King, L.; Fraser, R.; Forbes, M.; Grindley, M.; Ali, S.; Reid, M. Newborn sickle cell disease screening: The Jamaican experience (1995–2006). J. Med. Screen. 2007, 14, 117–122. [CrossRef] [PubMed]
Sabarense, A.P.; Lima, G.O.; Silva, L.M.; Viana, M.B. Survival of children with sickle cell disease in the comprehensive newborn screening programme in Minas Gerais, Brazil. Paediatr. Int. Child Health 2015, 35, 329–332. [CrossRef] [PubMed]
Quinn, C.T.; Rogers, Z.R.; Buchanan, G.R. Survival of children with sickle cell disease. Blood 2004, 103, 4023–4027. [CrossRef] [PubMed]
Quinn, C.T.; Rogers, Z.R.; McCavit, T.L.; Buchanan, G.R. Improved survival of children and adolescents with sickle cell disease. Blood 2010, 115, 3447–3452. [CrossRef] [PubMed]
Couque, N.; Girard, D.; Ducrocq, R.; Boizeau, P.; Haouari, Z.; Misud, F.; Holvoet, L.; Ithier, G.; Belloy, M.; Odièvre, M.H.; et al. Improvement of medical care in a cohort of newborns with sickle-cell disease in North Paris: Impact of national guidelines. Br. J. Haematol. 2016, 173, 927–937. [CrossRef] [PubMed]